BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31043479)

  • 1. Ribozyme-mediated, multiplex CRISPR gene editing and CRISPR interference (CRISPRi) in rodent-infectious
    Walker MP; Lindner SE
    J Biol Chem; 2019 Jun; 294(24):9555-9566. PubMed ID: 31043479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cas9 transgenic Plasmodium yoelii parasite for efficient gene editing.
    Qian P; Wang X; Yang Z; Li Z; Gao H; Su XZ; Cui H; Yuan J
    Mol Biochem Parasitol; 2018 Jun; 222():21-28. PubMed ID: 29684399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing in Plasmodium berghei made easy: Development of a CRISPR/Cas9 protocol using linear donor template and ribozymes for sgRNA generation.
    Deligianni E; Kiamos IS
    Mol Biochem Parasitol; 2021 Nov; 246():111415. PubMed ID: 34537287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient editing of malaria parasite genome using the CRISPR/Cas9 system.
    Zhang C; Xiao B; Jiang Y; Zhao Y; Li Z; Gao H; Ling Y; Wei J; Li S; Lu M; Su XZ; Cui H; Yuan J
    mBio; 2014 Jul; 5(4):e01414-14. PubMed ID: 24987097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential Activation of Guide RNAs to Enable Successive CRISPR-Cas9 Activities.
    Clarke R; Terry AR; Pennington H; Hasty C; MacDougall MS; Regan M; Merrill BJ
    Mol Cell; 2021 Jan; 81(2):226-238.e5. PubMed ID: 33378644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cpf1-Assisted Multiplex Genome Editing and Transcriptional Repression in Streptomyces.
    Li L; Wei K; Zheng G; Liu X; Chen S; Jiang W; Lu Y
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980561
    [No Abstract]   [Full Text] [Related]  

  • 7. Generation and functional characterisation of Plasmodium yoelii csp deletion mutants using a microhomology-based CRISPR/Cas9 method.
    Xu R; Liu Y; Fan R; Liang R; Yue L; Liu S; Su XZ; Li J
    Int J Parasitol; 2019 Aug; 49(9):705-714. PubMed ID: 31202685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized paired-sgRNA/Cas9 cloning and expression cassette triggers high-efficiency multiplex genome editing in kiwifruit.
    Wang Z; Wang S; Li D; Zhang Q; Li L; Zhong C; Liu Y; Huang H
    Plant Biotechnol J; 2018 Aug; 16(8):1424-1433. PubMed ID: 29331077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SgRNA Expression of CRIPSR-Cas9 System Based on MiRNA Polycistrons as a Versatile Tool to Manipulate Multiple and Tissue-Specific Genome Editing.
    Xie C; Chen YL; Wang DF; Wang YL; Zhang TP; Li H; Liang F; Zhao Y; Zhang GY
    Sci Rep; 2017 Jul; 7(1):5795. PubMed ID: 28724960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 12. Systematic CRISPR-Cas9-Mediated Modifications of
    Zhang C; Li Z; Cui H; Jiang Y; Yang Z; Wang X; Gao H; Liu C; Zhang S; Su XZ; Yuan J
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 mediated sequential editing of genes critical for ookinete motility in Plasmodium yoelii.
    Zhang C; Gao H; Yang Z; Jiang Y; Li Z; Wang X; Xiao B; Su XZ; Cui H; Yuan J
    Mol Biochem Parasitol; 2017 Mar; 212():1-8. PubMed ID: 28034675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficient genome editing in pathogenic mycobacteria using Streptococcus thermophilus CRISPR1-Cas9.
    Meijers AS; Troost R; Ummels R; Maaskant J; Speer A; Nejentsev S; Bitter W; Kuijl CP
    Tuberculosis (Edinb); 2020 Sep; 124():101983. PubMed ID: 32829077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
    Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
    Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium.
    Lee MCS; Lindner SE; Lopez-Rubio JJ; Llinás M
    Brief Funct Genomics; 2019 Sep; 18(5):281-289. PubMed ID: 31365053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dCas9-based genome editing in
    Zhang C; Yang S; Quansah E; Zhang Z; Da W; Wang B
    mSphere; 2024 Mar; 9(3):e0009524. PubMed ID: 38411120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.